BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hino O, Kobayashi T. Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex. Cancer Sci. 2017;108:5-11. [PMID: 27862655 DOI: 10.1111/cas.13116] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Chen H, Liu J, Wang H, Cheng Q, Zhou C, Chen X, Ye F. Inhibition of RNA-Binding Protein Musashi-1 Suppresses Malignant Properties and Reverses Paclitaxel Resistance in Ovarian Carcinoma. J Cancer 2019;10:1580-92. [PMID: 31031868 DOI: 10.7150/jca.27352] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
2 Sobczuk P, Brodziak A, Khan MI, Chhabra S, Fiedorowicz M, Wełniak-Kamińska M, Synoradzki K, Bartnik E, Cudnoch-Jędrzejewska A, Czarnecka AM. Choosing The Right Animal Model for Renal Cancer Research. Transl Oncol 2020;13:100745. [PMID: 32092671 DOI: 10.1016/j.tranon.2020.100745] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
3 Yao L, Alahmari M, Temel Y, Hovinga K. Therapy of Sporadic and NF2-Related Vestibular Schwannoma. Cancers (Basel) 2020;12:E835. [PMID: 32244314 DOI: 10.3390/cancers12040835] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
4 Strowd RE 3rd, Plotkin SR. Familial Nervous System Tumor Syndromes. Continuum (Minneap Minn) 2020;26:1523-52. [PMID: 33273171 DOI: 10.1212/CON.0000000000000950] [Reference Citation Analysis]
5 Huang X, Shao D, Wu H, Zhu C, Guo D, Zhou Y, Chen C, Lin Y, Lu T, Zhao B, Wang C, Sun Q. Genomic Profiling Comparison of Germline BRCA and Non-BRCA Carriers Reveals CCNE1 Amplification as a Risk Factor for Non-BRCA Carriers in Patients With Triple-Negative Breast Cancer. Front Oncol 2020;10:583314. [PMID: 33194720 DOI: 10.3389/fonc.2020.583314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Popiel A, Kobierzycki C, Dzięgiel P. The Role of Testin in Human Cancers. Pathol Oncol Res 2019;25:1279-84. [PMID: 30357755 DOI: 10.1007/s12253-018-0488-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Chen L, Zhang YH, Zhang Z, Huang T, Cai YD. Inferring Novel Tumor Suppressor Genes with a Protein-Protein Interaction Network and Network Diffusion Algorithms. Mol Ther Methods Clin Dev 2018;10:57-67. [PMID: 30069494 DOI: 10.1016/j.omtm.2018.06.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
8 Strowd RE. Available Therapies for Patients with Neurofibromatosis-Related Nervous System Tumors. Curr Treat Options in Oncol 2020;21. [DOI: 10.1007/s11864-020-00779-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
9 Tokutomi N, Nakai K, Sugano S. Extreme value theory as a framework for understanding mutation frequency distribution in cancer genomes. PLoS One 2021;16:e0243595. [PMID: 34424899 DOI: 10.1371/journal.pone.0243595] [Reference Citation Analysis]
10 Cohen E, Pena S, Mei C, Bracho O, Marples B, Elsayyad N, Goncalves S, Ivan M, Monje PV, Liu X, Fernandez-valle C, Telischi F, Dinh CT. Merlin-Deficient Schwann Cells Are More Susceptible to Radiation Injury than Normal Schwann Cells In Vitro. J Neurol Surg B Skull Base. [DOI: 10.1055/s-0040-1722283] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
11 Hino O, Abe M, Han B, Yan Y. In commemoration of the 2018 Mataro Nagayo Prize: A road to early diagnosis and monitoring of asbestos-related mesothelioma. Cancer Sci 2019;110:1518-24. [PMID: 30888083 DOI: 10.1111/cas.14001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kang Z, Zhu Y, Zhang QA, Dong L, Xu F, Zhang X, Guan M. Methylation and expression analysis of mismatch repair genes in extramammary Paget's disease. J Eur Acad Dermatol Venereol 2019;33:874-9. [PMID: 30784122 DOI: 10.1111/jdv.15404] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
13 McEneaney LJ, Tee AR. Finding a cure for tuberous sclerosis complex: From genetics through to targeted drug therapies. Adv Genet 2019;103:91-118. [PMID: 30904097 DOI: 10.1016/bs.adgen.2018.11.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
14 Yang ML, Huang Z, Wu LN, Wu R, Ding HX, Wang BG. lncRNA-PCAT1 rs2632159 polymorphism could be a biomarker for colorectal cancer susceptibility. Biosci Rep 2019;39:BSR20190708. [PMID: 31253700 DOI: 10.1042/BSR20190708] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
15 Hino O, Kobayashi T. Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex. Cancer Sci. 2017;108:5-11. [PMID: 27862655 DOI: 10.1111/cas.13116] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
16 Prakash A, Majumder S, Ahmad S, Varkey M, Anish TA, Jenkins C, Rigby M, Orsburn B. Detection and verification of 2.3 million cancer mutations in NCI60 cancer cell lines with a cloud search engine. J Proteomics 2019;209:103488. [PMID: 31445215 DOI: 10.1016/j.jprot.2019.103488] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Hedin U, Brunnström H, Dahlin M, Backman T, Perez de Sa V, Tran PK. Resolving the biological paradox of aneurysm formation in children with tuberous sclerosis complex. JVS Vasc Sci 2021;2:72-8. [PMID: 34617060 DOI: 10.1016/j.jvssci.2021.05.003] [Reference Citation Analysis]
18 Hong FU, Castro M, Linse K. Tumor-specific lytic path "hyperploid progression mediated death": Resolving side effects through targeting retinoblastoma or p53 mutant. World J Clin Oncol 2020;11:854-67. [PMID: 33312882 DOI: 10.5306/wjco.v11.i11.854] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]